共 50 条
- [1] Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6176 - 6193Zak, MarkMendonca, RohanBalazs, MercedeszBarrett, KathyBergeron, PhilippeBlair, Wade S.Chang, ChristineDeshmukh, GauriDeVoss, JasonDragovich, Peter S.Eigenbrot, CharlesGhilardi, NicoGibbons, PaulGradl, StefanHamman, ChrisHanan, Emily J.Harstad, EricHewitt, Peter R.Hurley, Christopher A.Jin, TianJohnson, AdamJohnson, TonyKenny, Jane R.Koehler, Michael F. T.Kohli, Pawan BirKulagowski, Janusz J.Labadie, SharadaLiao, JiangpengLiimatta, MaryaLin, ZhonghuaLupardus, Patrick J.Maxey, Robert J.Murray, Jeremy M.Pulk, RebeccaRodriguez, MadeleineSavage, ScottShia, StevenSteffek, MicahUbhayakar, SavitaUltsch, Markvan Abbema, AnneWard, Stuart I.Xiao, LingXiao, Yisong
- [2] Discovery and optimization of orally bioavailable, selective and potent ATP-independent Akt inhibitors[J]. CANCER RESEARCH, 2012, 72Chan, Thomas C. K.Ashwell, Mark A.Lapierre, Jean-MarcBrassard, ChristopherBull, CathyCornell-Kennon, SusanEathiraj, SudharshanFrance, Dennis S.Hill, JasonKoerner, SteffiKelleher, EoinKizer, DarinLiu, YanbinLink, JeffMakhija, SapnaMoussa, MagdiNamdev, NiveditaNicewonger, RobertUppalapati, UmaPalma, RocioSzwaya, JeffTandon, ManishVensel, DavidVolak, LaurieVolckova, ErikaWestland, NeilWu, HuiYang, Rui-Yang
- [3] Optimization of a series of potent, selective and orally bioavailable SYK inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (19)Grimster, Neil P.Gingipalli, LakshmaiahBarlaam, BernardSu, QibinZheng, XiaoLanWatson, DavidWang, HaixiaSimpson, IainPike, AndyBalazs, AmberBoiko, ScottIkeda, Timothy P.Impastato, Anna C.Jones, Natalie H.Kawatkar, SameerKemmitt, PaulLamont, ScottPatel, JoeRead, JonSarkar, UjjalSha, LiTomlinson, Ronald C.Wang, HaiyunWilson, David M.Zehnder, Troy E.Wang, LiangheWang, PengGoldberg, Frederick W.Shao, WenlinFawell, StephenDry, HannahDowling, James E.Edmondson, Scott D.
- [4] Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1887 - 1891Parthasarathy, SaravananHenry, KennethPei, HuaxingClayton, JoshRempala, MarkJohns, DeidreDe Frutos, OscarGarcia, PabloMateos, CarlosPleite, SehilaWang, YongStout, StephanieCondon, BradleyAshok, SheelaLu, ZhohaiEhlhardt, WilliamRaub, TomLai, MeiGeeganage, SandaruwanBurkholder, Timothy P.
- [5] Discovery of potent, selective, orally bioavailable Stearoyl-CoA desaturase 1 inhibitors[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (13) : 3086 - 3100Liu, GangLynch, John K.Freeman, JenniferLiu, BoXin, ZhiliZhao, HongyuSerby, Michael D.Kym, Philip R.Suhar, Tom S.Smith, Harriet T.Cao, NingYang, RuojingJanis, Rich S.Krauser, Joel A.Cepa, Steven P.Beno, David W. A.Sham, Hing L.Collins, Christine A.Surowy, Teresa K.Camp, Heidi S.
- [6] Identification of azabenzimidazoles as potent JAK1 selective inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (01) : 60 - 67Vasbinder, Melissa M.Alimzhanov, MaratAugustin, MartinBebernitz, GeraldineBell, KirstenChuaqui, ClaudioDeegan, TracyFerguson, Andrew D.Goodwin, KellyHuszar, DennisKawatkar, AartiKawatkar, SameerRead, JonShi, JieSteinbacher, StefanSteuber, HolgerSu, QibinToader, DorinWang, HaixiaWoessner, RichardWu, AllanYe, MinweiZinda, Michael
- [7] Discovery and optimization of pyrazole carboxamides as Jak1 selective inhibitors for rheumatoid arthritis[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248Zhang, HongjunSiliphaivanh, PhiengSiu, TonyTorres, LuisBrubaker, JasonNagayoshi, MasayukiMartinez, MichelleClose, JoshhuaChilders, MatthewMacCoss, RachelYoung, Jonathan R.Dinsmore, Christopher J.Jones, PhilLi, ChaominJung, JoonPickford, FionaDeshmukh, Sujal Vilas
- [8] Discovery and optimization of a novel series of highly selective JAK1 kinase inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258Grimster, NeilAnderson, EricaAlimzhanov, MaratBebernitz, GeraldineBell, KirstenChuaqui, ClaudioDeegan, TracyFerguson, AndrewGero, ThomasHarsch, AndreasHuszar, DennisKawatkar, AartiKettle, JasonLyne, PaulRead, JonCosta, Caroline RivardRuston, LinetteSchroeder, PatriciaShi, JieSu, QibinThroner, ScottToader, DorinVasbinder, MelissaWang, HaixiaWoessner, RichardWu, AllanYe, MinweiZheng, WeijiaZinda, Michael
- [9] Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (12) : 5235 - 5244Grimster, Neil P.Anderson, EricaAlimzhanov, MaratBebernitz, GeraldineBell, KirstenChuaqui, ClaudioDeegan, TracyFerguson, Andrew D.Gero, ThomasHarsch, AndreasHuszar, DennisKawatkar, AartiKettle, Jason G.Lyne, PaulRead, Jon A.Costa, Caroline RivardRuston, LinetteSchroeder, PatriciaShi, JieSu, QibinThroner, ScottToader, DorinVasbinder, MelissaWoessner, RichardWang, HaixiaWu, AllanYe, MinweiZheng, WeijiaZinda, Michael
- [10] Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (06): : 1005 - 1010Qin, DonghuiLin, XiaojuanLiu, ZhiChen, YanZhang, ZhiliuWu, ChengdeLiu, LinlinPan, YanLaquerre, SylvieEmery, JohnFergusson, JeffRoland, KimberlyKeenan, RickOliff, AllenKumar, SanjayCheung, MuiSu, Dai-Shi